SLRC Stock Analysis: SLR Investment | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 630m USD | 12M Return: -14.5% | US83413U1007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.64M
EPS Trend: -74.5%
Qual. Beats: 0
Rev. Trend: 34.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
SLR Investment Corp. (NASDAQ: SLRC) is a business development company (BDC) that provides financing to leveraged middle-market companies. Its investment offerings encompass secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital, and strategic income-oriented control equity investments. As a BDC, SLRC is regulated under the Investment Company Act of 1940 and is required to distribute substantially all of its taxable income to shareholders, making it a common choice for income-focused investors.
The company invests across a wide range of industries, including aerospace and defense, automotive, banking, beverage/food/tobacco, building products, commercial services, chemicals, construction, consumer finance, health care equipment and facilities, insurance, IT services, software, oil and gas, telecommunications, and utilities. Its life sciences investments focus on specialty pharmaceuticals, medical devices, and biotechnology. This broad sector diversification reflects the middle-market direct lending model typical of BDCs, which aim to spread credit risk while generating yield through floating-rate senior debt and structured equity positions.
- Fed rate cuts pressure SLRC floating-rate net interest margin
- Middle market credit deterioration lifts non-accruals and NAV write-downs
- Net investment income coverage of dividend remains key investor focus
| Net Income: 73.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.72 > 1.0 |
| NWC/Revenue: 754.8% < 20% (prev 27.63%; Δ 727.1% < -1%) |
| CFO/TA 0.05 > 3% & CFO 130.3m > Net Income 73.8m |
| Net Debt (-322.5m) to EBITDA (110.1m): -2.93 < 3 |
| Current Ratio: 6.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.0m) vs 12m ago 0.90% < -2% |
| Gross Margin: 66.05% > 18% (prev 59.12%; Δ 6.93% > 0.5%) |
| Asset Turnover: 7.00% > 50% (prev 6.53%; Δ 0.48% > 0%) |
| Interest Coverage Ratio: 1.56 > 6 (EBIT TTM 106.9m / Interest Expense TTM 68.5m) |
| A: 0.53 (Total Current Assets 1.61b - Total Current Liabilities 266.6m) / Total Assets 2.56b |
| B: -0.05 (Retained Earnings -133.5m / Total Assets 2.56b) |
| C: 0.04 (EBIT TTM 106.9m / Avg Total Assets 2.55b) |
| D: 0.62 (Book Value of Equity 982.1m / Total Liabilities 1.58b) |
| Altman-Z'' = 4.22 = AA |
As of October 07, 2026, the stock is trading at USD 11.43 with a total of 268,700 shares traded. Over the past week, the price has changed by -2.39%, over one month by -5.90%, over three months by -8.75% and over the past year by -14.51%.
Current recommended Stop Loss: 11.10 (which is 2.9% or 1.7 ATR below the current price).
SLR Investment has received a consensus analysts rating of 3.63. Therefore, it is recommended to hold SLRC.
- StrongBuy: 2
- Buy: 2
- Hold: 3
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 14.9 | 30.2% |
P/E Trailing = 8.4926
P/E Forward = 8.9928
P/S = 3.0068
P/B = 0.6546
P/EG = 4.3701
Revenue TTM = 178.5m USD
EBIT TTM = 106.9m USD
EBITDA TTM = 110.1m USD
Long Term Debt = 887.1m USD (estimated: total debt 1.15b - short term 266.6m)
Short Term Debt = 266.6m USD (from shortTermDebt, last quarter)
Debt = 1.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -322.5m USD (calculated: Debt 1.15b - CCE 1.48b)
Enterprise Value = 307.6m USD (630.1m + Debt 1.15b - CCE 1.48b)
Interest Coverage Ratio = 1.56 (Ebit TTM 106.9m / Interest Expense TTM 68.5m)
EV/FCF = 3.99x (Enterprise Value 307.6m / FCF TTM 77.2m)
FCF Yield = 25.09% (FCF TTM 77.2m / Enterprise Value 307.6m)
FCF Margin = 43.25% (FCF TTM 77.2m / Revenue TTM 178.5m)
Net Margin = 41.33% (Net Income TTM 73.8m / Revenue TTM 178.5m)
Gross Margin = 66.05% ((Revenue TTM 178.5m - Cost of Revenue TTM 60.6m) / Revenue TTM)
Gross Margin QoQ = 70.49% (prev 72.25%)
Tobins Q-Ratio = 0.12 (Enterprise Value 307.6m / Total Assets 2.56b)
Interest Expense / Debt = 5.94% (Interest Expense 68.5m / Debt 1.15b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 84.5m (EBIT 106.9m * (1 - 21.00%))
Current Ratio = 2.40 (Total Current Assets 1.61b / Total Current Liabilities 673.8m)
Debt / Equity = 1.17 (Debt 1.15b / totalStockholderEquity, last quarter 982.1m)
Debt / EBITDA = -2.93 (Net Debt -322.5m / EBITDA 110.1m)
Debt / FCF = -4.18 (Net Debt -322.5m / FCF TTM 77.2m)
Total Stockholder Equity = 990.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.89% (Net Income 73.8m / Total Assets 2.56b)
RoE = 7.45% (Net Income TTM 73.8m / Total Stockholder Equity 990.5m)
RoCE = 5.69% (EBIT 106.9m / Capital Employed (Equity 990.5m + L.T.Debt 887.1m))
RoIC = 3.31% (NOPAT 84.5m / Invested Capital 2.55b)
WACC = 5.61% (E(630.1m)/V(1.78b) * Re(7.29%) + D(1.15b)/V(1.78b) * Rd(5.94%) * (1-Tc(0.21)))
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 53.34 | Cagr: 0.40%
[DCF] Terminal Value 73.10% ; FCFF base≈84.2m ; Y1≈73.8m ; Y5≈59.7m
[DCF] Fair Price = 23.46 (EV 957.6m - Net Debt -322.5m = Equity 1.28b / Shares 54.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -74.54 | EPS CAGR: -4.87% | SUE: -0.35 | # QB: 0
Revenue Correlation: 34.51 | Revenue CAGR: 2.50% | SUE: -0.53 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.33 | Chg30d=-1.96% | Revisions=-50% | Analysts=7
EPS current Year (2026-12-31): EPS=1.31 | Chg30d=-1.23% | Revisions=-55% | GrowthEPS=-17.8% | GrowthRev=-10.3%
EPS next Year (2027-12-31): EPS=1.32 | Chg30d=-0.68% | Revisions=-38% | GrowthEPS=+1.3% | GrowthRev=+0.9%
[Analyst] Revisions Ratio: -63% (up=2, down=14)